|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Hormonal steroids in contraception: Report of a WHO scientific group. |
| World Health Organization Technical Report Series, No. 386. 1968. 28 p |
| Various new combinations of estrogens and progestogens for oral or injection application are being studied for their |
| contraceptive effectiveness, with the aim of finding the smallest dose with the most comprehensive effects. The |
| mechanism of oral steroids in contraception is still unclear, but research is concentrating on their effects on |
| hormone production and reproductive system tissues. The oral contraceptives have clinically displayed high |
| theoretical effectiveness. Possible side effects discussed include epithelial changes, dysmenorrhea, breast |
| cancer, reproductive ability changes, hepatic dysfunction, and hormonal alterations. Patient complaints have |
| frequently included various symptoms of nausea, weight gain, and headache. Oral steroid use is clearly |
| contraindicated in cancer, jaundice, or thromboembolic disease. Clinical reports indicate a rapidly growing use of |
| oral contraceptives with no discernible patterns as yet. It is recommended that the prescribing physician maintain a |
| careful watch over the patient through investigation of her history, regular physical examinations, and close |
| monitoring for adverse reactions. Research is encouraged into oral contraceptive formulas, mechanism, side effects |
| in the morphology and function of all aspects of the physiology, interaction with other drugs, and training of new |
| workers in human reproductive physiology. (PubHealth.info Document ID: CONT9T 1079-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Hormonal steroids in contraception: Report of a WHO |
| scientific group.", is(are) Kessler A. The source of this article is "World Health Organization Technical Report |
| Series, No. 386. 1968. 28 p". This article was published in 1968 in English language(s). (PubHealth.info® |
| Document ID: CONT9T 1079-06. All rights reserved with PubHealth.info) PIN: 41079 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |